Citrus flavonoids and lipid metabolism
- PMID: 23254473
- DOI: 10.1097/MOL.0b013e32835c07fd
Citrus flavonoids and lipid metabolism
Abstract
Purpose of review: Citrus flavonoids are polyphenolic compounds with powerful biological properties. This review aims to summarize recent advances towards understanding the ability of citrus flavonoids to regulate lipid metabolism and other metabolic parameters relevant to the metabolic syndrome, type 2 diabetes and cardiovascular disease.
Recent findings: Citrus flavonoids, including naringenin, hesperidin, nobiletin and tangeretin, have emerged as promising therapeutic agents for the treatment of metabolic dysregulation. Epidemiological studies report that intake of citrus flavonoid-containing foods attenuates cardiovascular diseases. Experimental and a limited number of clinical studies reveal lipid-lowering, insulin-sensitizing, antihypertensive and anti-inflammatory properties. In animal models, citrus flavonoid supplements prevent hepatic steatosis, dyslipidemia and insulin sensitivity primarily through inhibition of hepatic fatty acid synthesis and increased fatty acid oxidation. Citrus flavonoids blunt the inflammatory response in metabolically important tissues including liver, adipose tissue, kidney and the aorta. The mechanisms underlying flavonoid-induced metabolic regulation have not been completely established. In mouse models, citrus flavonoids show marked suppression of atherogenesis through improved metabolic parameters and also through direct impact on the vessel wall.
Summary: These recent studies suggest an important role of citrus flavonoids in the treatment of dyslipidemia, insulin resistance, hepatic steatosis, obesity and atherosclerosis. The favorable outcomes are achieved through multiple mechanisms. Human studies focussed on dose, bioavailability, efficacy and safety are required to propel the use of these promising therapeutic agents into the clinical arena.
Similar articles
-
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.Annu Rev Nutr. 2016 Jul 17;36:275-99. doi: 10.1146/annurev-nutr-071715-050718. Epub 2016 May 4. Annu Rev Nutr. 2016. PMID: 27146015 Review.
-
Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.J Agric Food Chem. 2008 Aug 13;56(15):6185-205. doi: 10.1021/jf8006568. Epub 2008 Jul 2. J Agric Food Chem. 2008. PMID: 18593176 Review.
-
Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice.Int J Biochem Cell Biol. 2006;38(7):1134-45. doi: 10.1016/j.biocel.2005.12.002. Epub 2006 Jan 6. Int J Biochem Cell Biol. 2006. PMID: 16427799
-
Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages.Atherosclerosis. 2005 Jan;178(1):25-32. doi: 10.1016/j.atherosclerosis.2004.07.034. Atherosclerosis. 2005. PMID: 15585197
-
Molecular mechanisms of citrus flavanones on hepatic gluconeogenesis.Fitoterapia. 2014 Jan;92:148-62. doi: 10.1016/j.fitote.2013.11.003. Epub 2013 Nov 15. Fitoterapia. 2014. PMID: 24239748
Cited by
-
The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro.Evid Based Complement Alternat Med. 2016;2016:2918796. doi: 10.1155/2016/2918796. Epub 2016 Sep 27. Evid Based Complement Alternat Med. 2016. PMID: 27761146 Free PMC article. Review.
-
Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial.Nutrients. 2024 Sep 20;16(18):3191. doi: 10.3390/nu16183191. Nutrients. 2024. PMID: 39339791 Free PMC article. Clinical Trial.
-
Elemental Metabolomics: Modulation of Egg Metallome with Flavonoids, an Exploratory Study.Antioxidants (Basel). 2019 Sep 1;8(9):361. doi: 10.3390/antiox8090361. Antioxidants (Basel). 2019. PMID: 31480630 Free PMC article.
-
Citrus Extract as a Perspective for the Control of Dyslipidemia: A Systematic Review With Meta-Analysis From Animal Models to Human Studies.Front Pharmacol. 2022 Feb 14;13:822678. doi: 10.3389/fphar.2022.822678. eCollection 2022. Front Pharmacol. 2022. PMID: 35237168 Free PMC article. Review.
-
Inhibitory Effect of Tangeretin and Cardamonin on Human Intestinal SGLT1 Activity In Vitro and Blood Glucose Levels in Mice In Vivo.Nutrients. 2021 Sep 26;13(10):3382. doi: 10.3390/nu13103382. Nutrients. 2021. PMID: 34684383 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials